BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22990801)

  • 1. 4(1H)-Quinolones with liver stage activity against Plasmodium berghei.
    Lacrue AN; Sáenz FE; Cross RM; Udenze KO; Monastyrskyi A; Stein S; Mutka TS; Manetsch R; Kyle DE
    Antimicrob Agents Chemother; 2013 Jan; 57(1):417-24. PubMed ID: 23129047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei.
    Onchieku NM; Mogire R; Ndung'u L; Mwitari P; Kimani F; Matoke-Muhia D; Kiboi D; Magoma G
    PLoS One; 2018; 13(8):e0201556. PubMed ID: 30067811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-Luciferase-Based Fast and Sensitive Detection of Malaria Hypnozoites for the Discovery of Antirelapse Compounds.
    Voorberg-van der Wel AM; Zeeman AM; Nieuwenhuis IG; van der Werff NM; Klooster EJ; Klop O; Vermaat LC; Kocken CHM
    Anal Chem; 2020 May; 92(9):6667-6675. PubMed ID: 32267675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of translation inhibitors on
    McLellan JL; Hanson KK
    Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38575357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioluminescent imaging of Arabidopsis thaliana using an enhanced Nano-lantern luminescence reporter system.
    Furuhata Y; Sakai A; Murakami T; Nagasaki A; Kato Y
    PLoS One; 2020; 15(1):e0227477. PubMed ID: 31899919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in the use of bioluminescence assays for drug discovery: an update of the last ten years.
    Calabretta MM; Michelini E
    Expert Opin Drug Discov; 2024; 19(1):85-95. PubMed ID: 37814480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Plasmodium vivax promoter elements in Plasmodium knowlesi, and a centromere-containing plasmid that expresses NanoLuc throughout the parasite life cycle.
    Moraes Barros RR; Thawnashom K; Gibson TJ; Armistead JS; Caleon RL; Kaneko M; Kite WA; Mershon JP; Brockhurst JK; Engels T; Lambert L; Orr-Gonzalez S; Adams JH; Sá JM; Kaneko O; Wellems TE
    Malar J; 2021 Jun; 20(1):247. PubMed ID: 34090438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of erythrocyte signalling pathways during Plasmodium falciparum infection identifies targets for host-directed antimalarial intervention.
    Adderley JD; John von Freyend S; Jackson SA; Bird MJ; Burns AL; Anar B; Metcalf T; Semblat JP; Billker O; Wilson DW; Doerig C
    Nat Commun; 2020 Aug; 11(1):4015. PubMed ID: 32782246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Screening of
    Colón-Lorenzo EE; Colón-López DD; Vega-Rodríguez J; Dupin A; Fidock DA; Baerga-Ortiz A; Ortiz JG; Bosch J; Serrano AE
    Front Pharmacol; 2020; 11():246. PubMed ID: 32256353
    [No Abstract]   [Full Text] [Related]  

  • 10. In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging.
    Avci P; Karimi M; Sadasivam M; Antunes-Melo WC; Carrasco E; Hamblin MR
    Virulence; 2018 Jan; 9(1):28-63. PubMed ID: 28960132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Generation of Marker-Free P. falciparum Fluorescent Reporter Lines Using Modified CRISPR/Cas9 Constructs and Selection Protocol.
    Mogollon CM; van Pul FJ; Imai T; Ramesar J; Chevalley-Maurel S; de Roo GM; Veld SA; Kroeze H; Franke-Fayard BM; Janse CJ; Khan SM
    PLoS One; 2016; 11(12):e0168362. PubMed ID: 27997583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycle.
    De Niz M; Stanway RR; Wacker R; Keller D; Heussler VT
    Malar J; 2016 Apr; 15():232. PubMed ID: 27102897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enlightening the malaria parasite life cycle: bioluminescent Plasmodium in fundamental and applied research.
    Siciliano G; Alano P
    Front Microbiol; 2015; 6():391. PubMed ID: 26029172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in molecular genetic systems in malaria.
    de Koning-Ward TF; Gilson PR; Crabb BS
    Nat Rev Microbiol; 2015 Jun; 13(6):373-87. PubMed ID: 25978707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro characterization of a Plasmodium liver stage-specific promoter.
    De Niz M; Helm S; Horstmann S; Annoura T; Del Portillo HA; Khan SM; Heussler VT
    PLoS One; 2015; 10(4):e0123473. PubMed ID: 25874388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insight-guided approaches to detect, cure, prevent and eliminate malaria.
    Kumar S; Kumari R; Pandey R
    Protoplasma; 2015 May; 252(3):717-53. PubMed ID: 25323622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging in NHP models of malaria: challenges, progress and outlooks.
    Beignon AS; Le Grand R; Chapon C
    Parasitol Int; 2014 Feb; 63(1):206-15. PubMed ID: 24042056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening inhibitors of P. berghei blood stages using bioluminescent reporter parasites.
    Lin JW; Sajid M; Ramesar J; Khan SM; Janse CJ; Franke-Fayard B
    Methods Mol Biol; 2013; 923():507-22. PubMed ID: 22990801
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.